Population
320 ischemic stroke survivors with nonvalvular atrial fibrillation at discharge from 40 centers in 5…
Comparison
Prescription of oral anticoagulation at discharge vs No prescription of oral anticoagulation at…
Design
Cross-sectional
Authors
Loading...
OAC underuse persists in eligible NVAF stroke patients; leaves open strategies targeting identified clinical and social barriers.
The prescription of oral anticoagulation at discharge for stroke survivors with NVAF remains underutilized and is significantly influenced by patient-related factors, social environment, and national practices.
Deplanque et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: